相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic value of post-treatment metabolic tumor volume from 11C-methionine PET/CT in recurrent malignant glioma
Tae-Young Jung et al.
NEUROSURGICAL REVIEW (2017)
Diagnostic and Prognostic Value of 11C-Methionine PET for Nonenhancing Gliomas
K. Takano et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
Usefulness of 11C-methionine positron emission tomography for treatment-decision making in cases of non-enhancing glioma-like brain lesions
Atsushi Watanabe et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Prediction of Posttransplantation Recurrence of Hepatocellular Carcinoma Using Metabolic and Volumetric Indices of 18F-FDG PET/CT
Yong-il Kim et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Preoperative Volume-Based PET Parameter, MTV2.5, as a Potential Surrogate Marker for Tumor Biology and Recurrence in Resected Pancreatic Cancer
Chang Moo Kang et al.
MEDICINE (2016)
Role of [11C] methionine positron emission tomography in the diagnosis and prediction of survival in brain tumours
Marta Cicuendez et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2015)
Prognostic value of volume-based measurements on 11C-methionine PET in glioma patients
Kentaro Kobayashi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients
Markus Hutterer et al.
NEURO-ONCOLOGY (2015)
Prognostic Value of Metabolic Tumor Volume on 11C-Methionine PET in Predicting Progression-Free Survival in High-Grade Glioma
Min Young Yoo et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2014)
Value of 11C-methionine PET in imaging brain tumours and metastases
Andor W. J. M. Glaudemans et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Response assessment of bevacizumab in patients with recurrent malignant glioma using [F-18]Fluoroethyl-l-tyrosine PET in comparison to MRI
Norbert Galldiks et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Prognostic Value of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography or PET-Computed Tomography in Cervical Cancer A Meta-Analysis
Qianying Zhao et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
11C-Methionine PET for Grading and Prognostication in Gliomas: A Comparison Study with 18F-FDG PET and Contrast Enhancement on MRI
Tarun Singhal et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Metabolic Tumor Volume Assessed by 18F-FDG PET/CT for the Prediction of Outcome in Patients with Multiple Myeloma
Rosa Fonti et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Volumetry of [11C]-Methionine Positron Emission Tomographic Uptake as a Prognostic Marker before Treatment of Patients with Malignant Glioma
Norbert Galldiks et al.
MOLECULAR IMAGING (2012)
French Brain Tumor DataBase: 5-Year Histological Results on 25 756 Cases
Valerie Rigau et al.
BRAIN PATHOLOGY (2011)
Prognostic Value of Metabolic Tumor Volume Measured by (18)F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Esophageal Carcinoma
Seung Hyup Hyun et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
METABOLIC TUMOR VOLUME PREDICTS FOR RECURRENCE AND DEATH IN HEAD-AND-NECK CANCER
Trang H. La et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
End Point Assessment in Gliomas: Novel Treatments Limit Usefulness of Classical Macdonald's Criteria
Martin J. van den Bent et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy
Yuzo Terakawa et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC) - A systematic review and meta-analysis (MA) by the European lung cancer working party for the IASLC lung cancer staging project
Thierry Berghmans et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Adding C-11-methionine PET to the EORTC prognostic factors in grade 2 gliomas
A. Smits et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas
N Galldiks et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Usefulness Of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma
T Nariai et al.
JOURNAL OF NEUROSURGERY (2005)
Baseline 11C-methionine PET reflects the natural course of grade 2 oligodendrogliomas
D Ribom et al.
NEUROLOGICAL RESEARCH (2005)
Direct comparison of F-18-FDG and C-11-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value
K Van Laere et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
C-11-methionine PET as a prognostic marker in patients with glioma: comparison with F-18-FDG PET
S Kim et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Positron emission tomography with injection of methionine as a prognostic factor in glioma
O De Witte et al.
JOURNAL OF NEUROSURGERY (2001)
分享论文
